DK536284D0 - Antipancreasinflammationspraeparater - Google Patents

Antipancreasinflammationspraeparater

Info

Publication number
DK536284D0
DK536284D0 DK536284A DK536284A DK536284D0 DK 536284 D0 DK536284 D0 DK 536284D0 DK 536284 A DK536284 A DK 536284A DK 536284 A DK536284 A DK 536284A DK 536284 D0 DK536284 D0 DK 536284D0
Authority
DK
Denmark
Prior art keywords
pct
antipancreas
inflammation
preparations
inflammations
Prior art date
Application number
DK536284A
Other languages
English (en)
Other versions
DK536284A (da
Inventor
Laszlo Madi-Szabo
Margit Morvai
Eva Horvath
Sandor Jancso
Piroska Tamasi
Istvan Kovacs
Ilona Maria Kiss
Gyoergy Bacsa
Maria Kubala
Magdolna Bene
Original Assignee
Biogal Gyogyszergyar
Alkaloida Vegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Gyogyszergyar, Alkaloida Vegyeszeti Gyar filed Critical Biogal Gyogyszergyar
Publication of DK536284D0 publication Critical patent/DK536284D0/da
Publication of DK536284A publication Critical patent/DK536284A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK536284A 1983-03-11 1984-11-09 Antipancreasinflammationspraeparater DK536284A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU83842A HU190072B (en) 1983-03-11 1983-03-11 Process for production of medical preparatives with sinergetic influence
PCT/HU1984/000016 WO1984003442A1 (en) 1983-03-11 1984-03-12 Pharmaceutical compositions of anti-pancreatic inflammatory effect

Publications (2)

Publication Number Publication Date
DK536284D0 true DK536284D0 (da) 1984-11-09
DK536284A DK536284A (da) 1984-11-09

Family

ID=10951646

Family Applications (1)

Application Number Title Priority Date Filing Date
DK536284A DK536284A (da) 1983-03-11 1984-11-09 Antipancreasinflammationspraeparater

Country Status (11)

Country Link
US (1) US4705779A (da)
EP (1) EP0137832B1 (da)
JP (1) JPS60500866A (da)
AT (1) ATE28794T1 (da)
AU (1) AU563697B2 (da)
DE (1) DE3465250D1 (da)
DK (1) DK536284A (da)
FI (1) FI844398A7 (da)
HU (1) HU190072B (da)
RO (1) RO92632B (da)
WO (1) WO1984003442A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10129725A1 (de) * 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) * 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005045518A1 (de) * 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
CA2624310C (en) 2005-10-04 2014-01-07 Bayer Healthcare Ag Polymorphic form of 5-chloro-n-({5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
DE102006051625A1 (de) * 2006-11-02 2008-05-08 Bayer Materialscience Ag Kombinationstherapie substituierter Oxazolidinone

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR917M (da) * 1961-02-10 1961-11-06
FR1611M (fr) * 1961-11-07 1962-12-17 Maurice Wahl Nouveau médicament, pour le traitement des congestions inflammatoires, en particulier des reins.
CH487171A (de) * 1963-10-22 1970-03-15 Siegfried Ag Verfahren zur Herstellung therapeutisch wirksamer 1,2-Dihydro-1,2,4-benztriazine
FR2128207B1 (da) * 1971-03-11 1974-08-02 Zyma Sa
GB1589294A (en) * 1976-09-08 1981-05-13 Inverni Della Beffa Spa Pharmaceutical compositions containing anthocyanidines
CA1100237A (en) * 1977-03-23 1981-04-28 Roger F.W. Pease Multiple electron beam exposure system
GB1595351A (en) * 1978-03-01 1981-08-12 Inverni Della Beffa Spa Pharmaceutical compositions containing flavylium compounds
FR2437838A1 (fr) * 1978-07-25 1980-04-30 Roecar Holdings Nv Medicament pour le traitement de l'adenome benin de la prostate
EP0028660B1 (de) * 1979-11-10 1985-10-23 Siegfried Aktiengesellschaft Xanthinoxydasehemmer und Verwendung von Benztriazinderivaten
US4325949A (en) * 1980-02-15 1982-04-20 American Cyanamid Company Combinations of agents which give enhanced anti-inflammatory activity
DE3047487A1 (de) * 1980-12-17 1982-07-08 Continental Pharma S.A., Bruxelles "pharmazeutische zubereitung zur behandlung von degenerativen erkrankungen der gelenkknorpel und verfahren zu ihrer verwendung"

Also Published As

Publication number Publication date
RO92632A (ro) 1987-10-30
DE3465250D1 (en) 1987-09-17
JPS60500866A (ja) 1985-06-06
FI844398A0 (fi) 1984-11-08
FI844398L (fi) 1984-11-08
EP0137832B1 (en) 1987-08-12
AU2696584A (en) 1984-09-28
FI844398A7 (fi) 1984-11-08
WO1984003442A1 (en) 1984-09-13
DK536284A (da) 1984-11-09
RO92632B (ro) 1987-10-31
HUT35520A (en) 1985-07-29
HU190072B (en) 1986-08-28
US4705779A (en) 1987-11-10
EP0137832A1 (en) 1985-04-24
ATE28794T1 (de) 1987-08-15
AU563697B2 (en) 1987-07-16

Similar Documents

Publication Publication Date Title
JO1552B1 (en) New pyridizinamine derivatives
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
ATE231839T1 (de) Polyaromatische antivirale zusammensetzungen
HUT77627A (hu) 2,2-Diklór-alkánkarbonsavak, eljárás előállításukra és ezeket tartalmazó, inzulinrezisztencia kezelésére alkalmazható gyógyszerkészítmények
PT758241E (pt) Utilizacao de certos derivados de acido metanobisfosfonico para impedir o desprendimento de proteses e a migracao de proteses
SE8204237L (sv) Karbostyrilforeningar, kompositioner innehallande dessa samt forfaranden for framstellning derav
IT8519327A0 (it) Derivati di furo-(3,4-c)-piridina 6-sostituiti,procedimento per laloro preparazione e composizioni terapeutiche che li contengono
AU1261583A (en) N-glycosylated carboxamide derivatives
CA2002859A1 (en) Method of treating epithelial disorders
DK536284A (da) Antipancreasinflammationspraeparater
IT8123940A0 (it) Derivati della s-adenosilmetionina, processo per la loro preparazione e composizioni terapeutiche che licontengono come principio attivo.
JPS5547657A (en) Fluorine contained 1*44dihydropyridine compound and medical use
ES8609312A1 (es) Procedimiento para la preparacion de silibinina exenta de isosilibina
IT1116848B (it) Perfezionamento nelle composizioni anti-virali particolarmente per il trattamento di infezioni rinovirali e procedimento per la loro preparazione
ZA859382B (en) New pyrrolobenzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing them
MA19882A1 (fr) Derives d'acides w-amines, leur preparation et utilisation ainsi que les compositions contenant ces acides.
DE3361990D1 (en) Alkylene-bridged guanidino-thiazole derivatives, method for their preparation and their use as medicaments
IT8323058A0 (it) Derivati di 2,5-piperazindione biologicamente attivi, processi per la loro preparazione e composizioni farmaceutiche che licontengono.
IT8348743A0 (it) Derivati di 2,5-diammino-1,4-diazolo,procedimento per prepararli e composizioni farmaceutiche che licontengono
DE2966809D1 (en) 3,4-diaza-bicyclo(4.1.0)hepten-2-ones-5, process for their preparation and therapeutical compositions containing them
DE3161193D1 (en) 5-aminotetrazole derivatives of retinoic acids, their preparation and pharmaceutical compositions containing them
IT8320920A0 (it) Derivati di cicloalcani, procedimento per la loro preparazione e composizioni che licontengono.
IT1228437B (it) "derivati di 2,3,4,5,6,7 esaidro 2,7-metano-1,5 benzossazonina (rispettivamente 1,4 benzossazonina), procedimento per la loro preparazione e prodotti medicinali che contengono questi composti.
DE69424679D1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
ATE28563T1 (de) Podophyllotoxin-zubereitungen fuer behandlung von genitalwarzen.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment